Products

Anti-EGFR ADCC Enhanced Antibody (Nimotuzumab) (AFC-TAB-710)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human EGFR. Nimotuzumab is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck.      

  • Datasheet

Specifications
Immunogen
The details of the immunogen for this antibody are not available.
Host
Human
Derivation
Humanized (from mouse)
Type
ADCC enhanced antibody
Species Reactivity
Human
Clone
Nimotuzumab
Applications
ELISA, IP, FC, FuncS, Neut, IF
Conjugate
Unconjugated
Trade name
Theracim
Generic Name
Nimotuzumab
Related Disease
Glioma cancers
Target
Alternative Names
Nimotuzumab; TheraCIM; 780758-10-3; hR3; h-R3; TheraCIM; BIOMAb EGFR; TheraCIM
Entrez Gene ID
1956
UniProt ID
P00533

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Verification code

Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Increase Efficiency to Accelerate Your Research & Discovery Process

Increase Efficiency to Accelerate Your Research & 
Discovery Process

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production ...

Find out more >

USA

45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356

Europe

Tel: 44-207-097-1828
Email:
Follow us on:
        

Terms of Service-Privacy Policy     © 2007 - 2019 Creative-Biolabs All Rights Reserved